Erythroid-produced intact FGF23 acts as a paracrine inhibitor of erythropoiesis, contributing to anemia in mice models of iron deficiency and chronic kidney disease.
- Open access
- 7 cites
Parathyroid Disorders and Treatments
Moving in Blood.
- Moved this week
- 1
Rebuilt
Moved this week
Latest in Parathyroid Disorders and Treatments
Newest first · last 60 days
Semaglutide reduces vascular resistance and prevents fibrosis in kidneys, supporting kidney function preservation in type 2 diabetes with chronic kidney disease.
- Open access
OsPHO2 promotes ubiquitin-dependent degradation of OsHMGB1, regulating phosphate homeostasis in rice by controlling PSR gene expression.
- Open access
Erythroid-produced intact FGF23 acts as a paracrine inhibitor of erythropoiesis, contributing to anemia in mice models of iron deficiency and chronic kidney disease.
- Open access
- 7 cites
Gla proteins influence cardiovascular disease and fibrosis through context-dependent mechanisms, with some functions independent of gamma-carboxylation, across multiple organs.
- Open access
Follow this area in the app
Browse JClub
Journals this month
- bioRxiv5569
- medRxiv1746
- Environ Res485
- PNAS463
- Sci Adv439
- JAMA255
- Cell Rep210
- BMJ205
- Nat Commun177
- Environ Pollution170
- Lancet149
- Science138
- NEJM119
- Applied & Environ Microbio116
- Curr Biol116
- J Exp Bot115
- mBio109
- Nature104
Moving areas, week to 3 Oct 2026
- Single-cell and spatial transcriptomics10
- Artificial Intelligence in Healthcare and Education8
- CAR-T cell therapy research7
- Neuroinflammation and Neurodegeneration Mechanisms6
- Lung Cancer Treatments and Mutations5
- Diabetes Treatment and Management4
- Pancreatic and Hepatic Oncology Research4
- Photosynthetic Processes and Mechanisms4
- Genomics and Chromatin Dynamics4
- Gut microbiota and health4